These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 33452612)
1. Bioinformatic analysis of dysregulated proteins in prostate cancer patients reveals putative urinary biomarkers and key biological pathways. Lima T; Henrique R; Vitorino R; Fardilha M Med Oncol; 2021 Jan; 38(1):9. PubMed ID: 33452612 [TBL] [Abstract][Full Text] [Related]
2. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer. Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962 [TBL] [Abstract][Full Text] [Related]
3. Discovery of novel candidate urinary protein biomarkers for prostate cancer in a multiethnic cohort of South African patients via label-free mass spectrometry. Adeola HA; Soares NC; Paccez JD; Kaestner L; Blackburn JM; Zerbini LF Proteomics Clin Appl; 2015 Jun; 9(5-6):597-609. PubMed ID: 25708745 [TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicle Proteome in Prostate Cancer: A Comparative Analysis of Mass Spectrometry Studies. Bernardino RMM; Leão R; Henrique R; Pinheiro LC; Kumar P; Suravajhala P; Beck HC; Carvalho AS; Matthiesen R Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948404 [TBL] [Abstract][Full Text] [Related]
5. Integration of Automatic Text Mining and Genomic and Proteomic Analysis to Unravel Prostate Cancer Biomarkers. Lima T; Ferreira R; Freitas M; Henrique R; Vitorino R; Fardilha M J Proteome Res; 2022 Feb; 21(2):447-458. PubMed ID: 35114790 [TBL] [Abstract][Full Text] [Related]
6. Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer. Li C; Zang T; Wrobel K; Huang JT; Nabi G Anal Bioanal Chem; 2015 May; 407(12):3393-404. PubMed ID: 25724369 [TBL] [Abstract][Full Text] [Related]
7. Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers. Mengual L; Lozano JJ; Ingelmo-Torres M; Izquierdo L; Musquera M; Ribal MJ; Alcaraz A BMC Cancer; 2016 Feb; 16():76. PubMed ID: 26856686 [TBL] [Abstract][Full Text] [Related]
8. Prostate cancer reshapes the secreted and extracellular vesicle urinary proteomes. Khoo A; Govindarajan M; Qiu Z; Liu LY; Ignatchenko V; Waas M; Macklin A; Keszei A; Neu S; Main BP; Yang L; Lance RS; Downes MR; Semmes OJ; Vesprini D; Liu SK; Nyalwidhe JO; Boutros PC; Kislinger T Nat Commun; 2024 Jun; 15(1):5069. PubMed ID: 38871730 [TBL] [Abstract][Full Text] [Related]
9. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue. Stephan C; Jung M; Rabenhorst S; Kilic E; Jung K Clin Chem Lab Med; 2015 Jun; 53(7):1109-18. PubMed ID: 25720086 [TBL] [Abstract][Full Text] [Related]
10. Screening, identification of prostate cancer urinary biomarkers and verification of important spots. Zhao H; Zhao X; Lei T; Zhang M Invest New Drugs; 2019 Oct; 37(5):935-947. PubMed ID: 30610587 [TBL] [Abstract][Full Text] [Related]
12. The discovery of putative urine markers for the specific detection of prostate tumor by integrative mining of public genomic profiles. Chen M; Wang K; Zhang L; Li C; Yang Y PLoS One; 2011; 6(12):e28552. PubMed ID: 22194848 [TBL] [Abstract][Full Text] [Related]
13. Combined serum and EPS-urine proteomic analysis using iTRAQ technology for discovery of potential prostate cancer biomarkers. Zhang M; Chen L; Yuan Z; Yang Z; Li Y; Shan L; Yin B; Fei X; Miao J; Song Y Discov Med; 2016 Nov; 22(122):281-295. PubMed ID: 28009970 [TBL] [Abstract][Full Text] [Related]
14. Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers. Tsoi TH; Chan CF; Chan WL; Chiu KF; Wong WT; Ng CF; Wong KL PLoS One; 2016; 11(9):e0162217. PubMed ID: 27598335 [TBL] [Abstract][Full Text] [Related]
15. Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine. Lima AR; Pinto J; Azevedo AI; Barros-Silva D; Jerónimo C; Henrique R; de Lourdes Bastos M; Guedes de Pinho P; Carvalho M Br J Cancer; 2019 Nov; 121(10):857-868. PubMed ID: 31588123 [TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes. Hendriks RJ; Dijkstra S; Jannink SA; Steffens MG; van Oort IM; Mulders PF; Schalken JA Clin Chem Lab Med; 2016 Mar; 54(3):483-92. PubMed ID: 26630694 [TBL] [Abstract][Full Text] [Related]
17. Recent progress in urinary proteome analysis for prostate cancer diagnosis and management. Frantzi M; Latosinska A; Merseburger AS; Mischak H Expert Rev Mol Diagn; 2015; 15(12):1539-54. PubMed ID: 26491818 [TBL] [Abstract][Full Text] [Related]
18. Detection of miRNAs in urine of prostate cancer patients. Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485 [TBL] [Abstract][Full Text] [Related]
19. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method. Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988 [TBL] [Abstract][Full Text] [Related]
20. Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery. Lee B; Mahmud I; Marchica J; Dereziński P; Qi F; Wang F; Joshi P; Valerio F; Rivera I; Patel V; Pavlovich CP; Garrett TJ; Schroth GP; Sun Y; Perera RJ Sci Rep; 2020 Feb; 10(1):3716. PubMed ID: 32111915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]